Nora Pashayan is a Professor of Applied Cancer Research at UCL Institute of Epidemiology and Healthcare and an Honorary Consultant in Public Health Medicine. She is qualified in medicine (American University of Beirut), specialized in both family medicine and public health medicine, and qualified in both epidemiology (LSHTM) and public health (University of Cambridge). Nora’s research is in risk-stratified cancer screening, from modeling the natural history of cancer, identifying risk-stratified screening strategies that optimise the benefit-harm balance and the cost-effectiveness of the screening programmes, to preparing for implementation of such programmes.
In this session, Nora will cover how early is early, why one-size does not fit all, and how risk-stratification could optimise the benefit-harm balance of early detection programmes.
